Novel Technologies

Novel Technologies

Two subcutaneous therapies are currently being investigated.Read More
MLOF is open to all people with hemophilia A and B.Read More
More than 100 researchers met for NHF's 13th Workshop on Novel Technologies and Gene Transfer for Hemophilia.Read More
The MLOF Research Repository will allow researchers to explore long-unanswered questions about hemophilia.Read More
All six of the most common genotypes of the hepatitis C virus (HCV) have a new foe: Epclusa®, manufactured by...Read More
I attended the National Hemophilia Foundation’s (NHF’s) 12th Workshop on Novel Technologies and Gene Transfer for Hemophilia at Georgetown University...Read More
Five pilot sites have been approved and first patients enrolledRead More
A workshop on new bleeding disorders therapies provided insights on improved clotting factors, immune responses to new treatments and gene...Read More
Chat Icon
Need Info? Ask NHF!
Contact HANDI, NHF's resource center for additional information on bleeding disorders.